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Abstract. 
 
The short filaments extending from the cyto-
plasmic face of nuclear pore complexes are thought to 
contain docking sites for nuclear import substrates. 
One component of these filaments is the large O-linked 
glycoprotein CAN/Nup214. Immunoprecipitation stud-
ies carried out under nondenaturing conditions, and us-
ing a variety of antibodies, reveal a novel nonglycosy-
lated nucleoporin, Nup84, that is tightly associated with 
CAN/Nup214. Consistent with such an association, 
Nup84 is found to be exposed on the cytoplasmic face 
of the nuclear pore complex. cDNA sequence analyses 
indicate that Nup84 contains neither the GLFG nor the 
XFXFG repeats that are a characteristic of a number of 
other nuclear pore complex proteins. Secondary struc-
ture predictions, however, suggest that Nup84 contains 
a coiled–coil COOH-terminal domain, a conclusion 
supported by the observation of significant sequence 
similarity between this region of the molecule and vari-
ous members of the tropomyosin family. Mutagenesis 
and expression studies indicate that the putative 
coiled–coil domain is required for association with the 
cytoplasmic face of the nuclear pore complex, whereas 
it is the NH
 
2
 
-terminal region of Nup84 that contains the 
site of interaction with CAN/Nup214. These findings 
suggest a model in which Nup84 may function in the at-
tachment of CAN/Nup214 to the central framework of 
the nuclear pore complex. In this way, Nup84 could 
play a central role in the organization of the interface 
between the pore complex and the cytoplasm.
 
N
 
uclear 
 
pore complexes (NPCs)
 
1
 
 are large and ex-
tremely elaborate structures that mediate the bi-
directional traffic of macromolecules across the
nuclear envelope (Melchior and Gerace, 1995). Extensive
high resolution EM observations of amphibian oocyte
NPCs have recently laid the foundations of a consensus
model of NPC architecture (for reviews see Goldberg and
Allen, 1995; Panté and Aebi, 1994), the central feature of
which is a massive symmetrical framework (120 
 
3
 
 80 nm)
embedded in the double membranes of the nuclear enve-
lope. This framework appears as eight radial multidomain
spokes, connected at their distal ends, and on both their
nuclear and cytoplasmic faces, by multisubunit rings (Akey,
1995; Akey and Radermacher, 1993; Hinshaw et al., 1992).
The whole assembly embraces a large central gated chan-
nel, of as yet ill-defined structure, that may accommodate
particles with diameters up to 26 nm, provided that they
bear specific nuclear import/export signals. In addition to
the central channel, the framework itself contains eight ad-
ditional peripheral channels that are located in the vicinity
of the junction between the inner and outer nuclear mem-
branes. These peripheral channels are thought to permit
the free exchange of small molecules (
 
,
 
10 nm in diame-
ter) between the nucleus and the cytoplasm.
In addition to the central framework or ring–spoke com-
plex, NPCs also possess extensive peripheral structures ex-
tending into both the cytoplasm and the nuclear interior
(Ris, 1991). Projecting from the cytoplasmic ring are eight
short (
 
z
 
100 nm) filaments which are thought to contain
docking sites for proteins en route to the nucleus (Panté
and Aebi, 1996; Richardson et al., 1988). Protruding from
the nucleoplasmic face of the central framework of the
NPC are eight 50–100-nm-long filaments joined at their
distal ends by a 30–50-nm-diameter ring. Together these
form a structure resembling a basket or fishtrap, the func-
tion of which is currently unclear. It may however, by anal-
ogy with the cytoplasmic filaments, contain docking sites
for translocating molecules (Bastos et al., 1996). From a
morphological and probably functional perspective, the ef-
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fect of these peripheral structures is to endow the NPC
with an overall asymmetry about an axis parallel to the
plane of the nuclear membranes.
Biophysical analyses of Xenopus oocyte NPCs have in-
dicated that they have a total mass of about 125 MD (Reich-
elt et al., 1990), 30 times that of a ribosome. It has been
suggested that the NPC may be composed of as many as
100 different protein subunits based partly on these find-
ings. During the past few years a number of these proteins
have been identified and characterized at the molecular
level. However, even assuming quite generous stoichiome-
tries, these can account for only a minor fraction of the
vertebrate NPC mass (for reviews see Bastos et al., 1995;
Rout and Wente, 1994). For the majority of the known
vertebrate NPC proteins or nucleoporins, only sketchy in-
formation is available concerning their precise location
within the NPC as well as the nature of their interactions
with neighboring subunits. Nevertheless, since the NPC
functions vectorially, this type of information is essential if
we are to gain a clear understanding of the mechanisms of
macromolecular translocation across the nuclear envelope.
We have previously described a protein complex that
may be released directly from vertebrate NPCs and that
contains two dissimilar subunits, a 250-kD protein modi-
fied with O-linked 
 
N
 
-acetylglucosamine (O-GlcNAC) and
a carbohydrate-free 75-kD protein (Panté et al., 1994).
The estimated mass of this heterooligomer is 
 
z
 
1–2 MD. It
is now clear that the 250-kD glycoprotein is identical to a
potential oncoprotein called CAN (Bastos, R., and B.
Burke, unpublished results), rearrangements in the gene
for which are associated certain leukemias (von Lindern et
al., 1992). CAN was subsequently found to correspond to
Nup214, an NPC protein (Kraemer et al., 1994). Using
high resolution immunogold electron microscopy, CAN/
Nup214 has been localized within the NPC to the short fil-
aments that extend from the cytoplasmic face of the ring–
spoke complex (Panté et al., 1994). More recently, gene
targeting experiments in embryonic stem cells have dem-
onstrated that CAN/Nup214 is an essential NPC compo-
nent (van Deursen et al., 1996). Early mouse embryos that
are homozygous for the disrupted CAN/Nup214 allele are
inviable and exhibit impaired nucleocytoplasmic transport
accompanied by cell cycle arrest. At the same time these
embryos exhibit morphologically identifiable NPCs that
contain other members of the O-linked NPC glycoprotein
family. This latter observation is consistent with the pe-
ripheral localization of CAN/Nup214 as well as earlier
studies concerning the role of O-linked glycoproteins in
NPC function and assembly (Finlay and Forbes, 1990). In
this paper, we report the molecular characterization of the
75-kD protein associated with CAN/Nup214. The cDNA
encodes a novel nucleoporin with a calculated molecular
mass of 84 kD. Therefore, following the current nomencla-
ture convention it will be referred to as Nup84. It does not
belong to the O-linked glycoprotein family of nuclear pore
complex proteins and it does not contain the characteristic
XFXFG or GLFG repeats that are observed in other nu-
cleoporins of both higher and lower cells. The predicted
structure of this molecule combined with expression and
deletion analyses suggests that it could be involved in the
attachment of CAN/Nup214 to the cytoplasmic face of the
NPC.
 
Materials and Methods
 
Cell Culture
 
BHK, BHKgr
 
b
 
, NRK, and HeLa cells were maintained in a 7.5% CO
 
2
 
 at-
mosphere at 37
 
8
 
C. All of the cells were cultured in DME (GIBCO BRL,
Gaithersburg, MD) containing 10% fetal bovine serum (HyClone, Logan,
UT), 100 
 
m
 
g/ml of penicillin/streptomycin (GIBCO BRL) and 2 mM
glutamine (GIBCO BRL).
 
Antibodies
 
The QE5 monoclonal antibody and a guinea pig polyclonal antibody that
recognizes CAN/Nup214 have been described by Panté et al. (1994). For
QE5 immunoadsorption experiments an affinity matrix of QE5 IgG co-
valently coupled to protein G-Sepharose using dimethylpimelimidate was
prepared following published procedures (Harlow and Lane, 1988). An
antibody against Nup84 was raised in rabbits by BAbCO (Berkeley, CA)
using the synthetic peptide QINDIRNHVNF, which corresponds to the
last 11 residues of the COOH terminus deduced from the cDNA se-
quence. The rabbit antipeptide antibody specific for human lamin A has
been previously described (Burke, 1990). Human autoantibodies against
the nuclear pore complex protein gp210 were gifts from Dr. Jean-Claude
Courvalin (Institute Jacques Monod, Paris) and Dr. Marvin Fritzler (Uni-
versity of Calgary, Alberta, Canada). The polyclonal rabbit antibodies
raised against recombinant importin-
 
a
 
 and importin-
 
b
 
 were a gift from
Dr. Manfred Lohka (University of Calgary, Alberta, Canada) and Dr. Au-
relian Radu (The Rockefeller University, New York), respectively. The
monoclonal antibody against LGP120 was provided by Dr. Jean Gruen-
berg (University of Geneva, Switzerland). The anti-HA monoclonal anti-
body (12CA5) was obtained from BAbCO and the polyclonal rabbit anti-
HA antibody was provided by Medical and Biological Laboratories (Wa-
tertown, MA). The anti-cMyc monoclonal antibody (9E10) was obtained
from the American Type Culture Collection (Rockville, MD). The
rhodamine and FITC-conjugated secondary antibodies were purchased
from Tago, Inc. (Burlingame, CA). For use in double label experiments,
the secondary antibodies were cross adsorbed, as appropriate, against ei-
ther mouse or rabbit IgG covalently coupled to cyanogen bromide-acti-
vated Sepharose CL 4B.
 
Purification of Nup84 and Protein Sequencing
 
Nup84 was purified from high salt/detergent extracts of rat liver nuclear
envelopes using a QE5 affinity matrix prepared as described above.
Briefly, nuclei were isolated from 30-g batches of rat livers according to
published methods (Blobel and Potter, 1966) and, from these, nuclear en-
velopes (NE) were prepared after DNase and RNase digestion (Dwyer
and Blobel, 1976). NEs were then extracted in a solution containing: 50
mM triethanolamine, pH 7.4, 500 mM NaCl, 0.5% Triton X-100, 1 mM
DTT, and protease inhibitors. The soluble material was adsorbed to QE5
IgG cross-linked to protein G-Sepharose beads and, after extensive
washes in the same solution, adsorbed proteins were eluted with SDS-
PAGE sample buffer. Typically, 4–10 
 
m
 
g of Nup84 protein (on the order
of 50–100 pmol) could be recovered from about 100 g of liver tissue, suffi-
cient to obtain reliable internal sequence information.
For internal amino acid sequence analysis the procedure described in
(Aebersold et al., 1987) was followed. In brief, the eluate was electro-
phoretically fractionated and electroblotted onto a nitrocellulose mem-
brane and protein bands were identified by Ponceau S staining. The band
corresponding to Nup84 was excised and digested in situ with trypsin. The
resulting peptides were separated by micro-bore reverse-phase HPLC and
sequenced in a gas-phase sequenator. All of these operations on the mem-
brane-adsorbed protein were carried out by the Harvard University Mi-
cro-Chemistry Facility (Cambridge, MA) under the direction of Dr. W.
Lane.
 
Cloning of cDNAs Encoding Rat and Human Nup84
 
One of the three peptide sequences obtained (P1) was used to design a
“guessmer” of 45 bp. This is a single oligonucleotide where the substitu-
tions at each position of ambiguity were chosen on the statistical basis of
known codon utilization in the species of interest (Lathe, 1985).To clone
the rat cDNA, the 45-mer was end-labeled with 
 
g
 
-[
 
32
 
P]ATP (New En-
gland Nuclear, Boston, MA) using polynucleotide kinase (New England
Biolabs, Beverly, MA) and used to screen about a half million recombi- 
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nants of a rat thyroid Uni-ZAP library (Stratagene, La Jolla, CA). Plaque
lifts were prepared following established procedures and prehybridized at
48
 
8
 
C for 2–3 h in a solution containing 6
 
3
 
 SSC and 1% Sarkosyl (ICN
Biochemicals, Cleveland, OH). Hybridization was performed under the
same conditions for 24 h. Filters were washed several times in the same so-
lution at increasing temperatures up to 65
 
8
 
C. A single positive clone was
plaque purified and pBluescript SK (
 
2
 
) containing the cDNA insert was
excised in vivo, rescued, and sequenced.
The full-length sequence was obtained using the 5
 
9
 
-AmpliFINDER
RACE Kit (Clontech, Palo Alto, CA). Poly (A)
 
1
 
 RNA for this experi-
ment was prepared from NRK cells using the FAST TRACK mRNA iso-
lation kit (Invitrogen, San Francisco, CA). The ZAP and the RACE
clones both cloned in pBluescript SK (
 
2
 
) were pasted together using a
convenient SphI site in the overlapping region.
To clone the human homologue of Nup84, a lambda gt10 human T cell
library (generously provided by Dr. Frank McKeon, Harvard Medical
School, Boston, MA) was screened with the 500-bp EcoRI-NsiI cDNA
fragment corresponding to the 5
 
9
 
 region of the original rat clone. Hybrid-
izations were carried out overnight at 42
 
8
 
C in a solution containing 5
 
3
 
SSC, 50% formamide, 5
 
3
 
 Denhardt’s solution, 0.5% SDS, and 100 
 
m
 
g/ml
denatured salmon sperm DNA. Filters were washed several times in 2
 
3
 
SSC/0.5% SDS at the same temperature and once in 1
 
3
 
 SSC/0.5% SDS at
52
 
8
 
C. Two positive clones were plaque purified. Phage DNA was pre-
pared from 50-ml lysates and cDNA inserts were subcloned into pBS and
sequenced.
 
Sequence Analysis and Prediction of
Secondary Structure
 
The complete sequence of the cDNA was carried out by PCR using fluo-
rescently tagged dideoxynucleoside terminators by the Biopolymer Facil-
ity at the Harvard Medical School. Sequence database searching was per-
formed using BLAST (Altschul et al., 1990). The sequence alignments
were accomplished employing the pair-wise alignment program PILEUP
(GCG package). For the secondary structure predictions the neural net-
work method implemented by the program PHD (Rost and Sander, 1993)
was used.
 
Northern Blot Analysis and In Vitro Translation Assay
 
A multiple rat tissue Northern blot containing 2 
 
m
 
g of poly A
 
1
 
 per lane
was probed with a 500-bp EcoRI-NsiI fragment from the original rat
cDNA clone according to the manufacturer’s procedure (Clontech). For
the in vitro translation assay, the full-length cDNA of Nup84 (EcoRI-
XhoI) was subcloned into pSP73 (Promega, Madison, WI). 1 
 
m
 
g of pSP73-
Nup84 was in vitro transcribed using the SP6 polymerase and translated
using a TNT-coupled reticulocyte lysate system (Promega) according to
the manufacturer’s protocol in a final volume of 25 
 
m
 
l per assay.
 
Immunofluorescence Microscopy
 
Cells grown on glass coverslips were fixed with formaldehyde and labeled
with antibodies according to previously described procedures (Ash et al.,
1977). In short, cells were fixed for 20 min at room temperature in 3%
formaldehyde (prepared from paraformaldehyde dissolved at 80
 
8
 
C in
phosphate-buffered saline). After PBS washes, the fixed cells were perme-
abilized for 5 min at room temperature with 0.2% Triton X-100 in PBS
and labeled with appropriate primary and secondary antibodies. In addi-
tion some samples were stained with the DNA-specific Hoechst dye 33258
(Hoechst, La Jolla, CA) to reveal the cell nuclei. For differential perme-
abilization experiments (in which only the cytoplasmic face of the nuclear
envelope is exposed to antibody) cells were instead treated for 15 min at
4
 
8
 
C with 0.004% digitonin in PBS (Panté et al., 1994). The digitonin was
prepared from a 10% stock solution in dimethyl sulfoxide. Integrity of the
nuclear membranes in digitonin permeabilized cells was always confirmed
using a rabbit anti–lamin A antibody (Burke, 1990). Specimens were ob-
served and photographed under appropriate illumination with either a
Zeiss Axiophot microscope equipped with a X63 PlanApo objective lens
or a Leica DMRB microscope equipped with a X63 PL APO NA1.4 ob-
jective.
 
Immunoprecipitations and Immunoblotting
 
For long-term labeling, transfected (below) or mock transfected cells
grown in 35-mm tissue culture dishes were labeled overnight with 50 
 
m
 
Ci
 
35
 
S-Trans label (ICN) in 1 ml growth medium containing methionine and
cysteine at 10% of their normal concentrations. Immunoprecipitation
analysis was carried out as we have previously described. In short, the cells
were washed once in PBS and then lysed in a buffer (TNX) containing 50
mM triethanolamine (TEA), 500 mM NaCl, 0.5% Triton X-100, 1 mM
DTT, 1 mM PMSF, and 1:1,000 CLAP (10 mg/ml in DMSO of each of the
following, chymostatin, leupeptin, antipain, and pepstatin).The lysate was
centrifuged for 10 min at full speed in an Eppendorf cooled to 4
 
8
 
C. To the
supernatant was added either 20 
 
m
 
l of a QE5 affinity matrix consisting of a
50% suspension of protein G-Sepharose to which QE5 IgG had been
chemically cross-linked (above) or 5 
 
m
 
l of appropriate antiserum/ascites
fluid and 20 
 
m
 
l protein A-Sepharose (50% suspension). The mixture was
then rotated overnight at 4
 
8
 
C. The following morning the QE5 beads were
washed five times in either the same buffer or in a higher stringency buffer
containing 50 mM TEA, 100 mM NaCl, 0.5% Triton X-100, 0.1% SDS, 1
mM DTT, 1 mM PMSF, and 1:1,000 CLAP (Panté et al., 1994). After two
final washes in 50 mM Tris, pH 7.4, the QE5 beads were suspended in
SDS-polyacrylamide gel sample buffer and fractionated by electrophore-
sis (Laemmli, 1970). On completion of electrophoresis, gels, where neces-
sary, were blotted onto nitrocellulose filters (BA85; Schleicher and Schuell,
Keene, NH [Burnette, 1981]) using a semi-dry blotting apparatus manu-
factured by Hoeffer Scientific Instruments, Inc. (San Francisco, CA). Fil-
ters were blocked, labeled with primary antibodies, and then developed
with peroxidase conjugated secondary antibodies exactly as previously de-
scribed (Burke et al., 1982). Alternatively, radioactive gels were examined
by fluorography following impregnation with Amplify (Amersham, Ar-
lington Heights, IL) and exposure to Kodak X-Omat AR x-ray film at
 
2
 
70
 
8
 
C.
For pulse-chase experiments, BHK cells in 35-mm petri dishes were
preincubated for 10 min at 37
 
8
 
C in DME lacking methionine and cysteine.
The cells were subsequently labeled for periods up to 30 min in 0.5 ml of
methionine- and cysteine-free DME containing 5% dialyzed (against
PBS) fetal bovine serum and 60 
 
m
 
Ci 
 
35
 
S-Trans label. For the chase (where
appropriate), 1 ml of complete BHK growth medium, containing 10 times
the normal concentration of methionine and cysteine, was added directly
to the cells and the incubation continued for the desired time. Pulse la-
beled cells were then lysed on ice in 1 ml of a low salt solution containing
50 mM TEA, 0.5% Triton X-100, 1 mM DTT, 1 mM PMSF and 1:1,000
CLAP. The lysed cells were centrifuged for 2 min at 3,000 rpm in an Ep-
pendorf centrifuge maintained at 4
 
8
 
C. The supernatant was removed and
NaCl added to a final concentration of 500 mM from a 4 M stock. The pel-
let was reextracted in 1 ml of the high salt TNX buffer (above). Both the
low salt supernatant and the high salt pellet extract were cleared by cen-
trifugation in the cold for 10 min at full speed in an Eppendorf centrifuge.
The samples were subsequently processed for immunoprecipitation as de-
scribed above.
 
Expression of Rat Nup84 and CAN/Nup214 in 
Mammalian Cells
 
The cDNA coding for the rat Nup84 was cloned into the mammalian
CMV driven expression vector pcDNA3 (Invitrogen) containing a 200-bp
5
 
9
 
-untranslated sequence from human lamin A and either an NH
 
2
 
-termi-
nal HA or cMyc epitope tag. The cloning strategy took advantage of the
polymerase chain reaction and utilized oligonucleotide primers incorpo-
rating suitable restriction sites at their 5
 
9
 
 ends (Xho1 or Cla1). The HA-
tagged construct of CAN/Nup214 was kindly provided by Dr. Gerard
Grosveld (St. Jude Children’s Research Hospital, Memphis, TN). The
HA-tagged Nup153 construct has been previously described (Bastos et al.,
1996). For immunofluorescence experiments, typically 1 
 
m
 
g of cesium
chloride-purified plasmid DNA was introduced into cells growing on cov-
erslips using the calcium phosphate method. For immunoprecipitation and
immunoblot analysis the DNA was introduced using the Lipofectamine
reagent exactly as described by the manufacturer (GIBCO BRL).
 
Results
 
Identification, Purification, and cDNA Cloning
of Nup84
 
We have previously described a monoclonal antibody (QE5)
that recognizes three members of the O-linked glycopro-
tein family of nuclear pore complex proteins: p62, Nup153, 
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and CAN/Nup214 (Panté et al., 1994). However, QE5 im-
munoprecipitates prepared under nondenaturing condi-
tions were found to contain four additional polypeptides
of apparent molecular mass of 75, 58, 54, and 45 kD (Panté
et al., 1994). p58, p54, and p45 had been shown by others
to be associated with p62 (Finlay et al., 1991; Guan et al.,
1995; Kita et al., 1993), while p75 appeared to be a novel
protein and was associated with CAN/Nup214 in a large
(1–2 MD) complex. In view of the location of CAN/
Nup214 in the cytoplasmic filaments of the NPC, this 75-
kD protein was predicted to be a nucleoporin exposed on
the cytoplasmic face of the NPC (Panté et al., 1994).
To further characterize this protein we took advantage
of its association with CAN/Nup214 and hence its appear-
ance in QE5 immunoprecipitates. An affinity matrix of
QE5 IgG covalently attached to protein G-Sepharose beads
was used to immunoadsorb high salt/detergent extracts of
purified rat liver nuclear envelopes. The immunoadsorbed
material contained six out of the seven proteins described
above in roughly stoichiometric quantities (the wash con-
ditions used here tend to strip p45 from the immunopre-
cipitate) and is documented in a pilot experiment shown in
Fig. 1 
 
A.
 
 Large scale QE5 immunoprecipitates prepared in
this way were fractionated by electrophoresis to yield mi-
crogram quantities of gel purified protein that was subse-
quently used for amino acid sequence analysis. Typically,
between 50 and 100 pmol of the 75-kD protein was ob-
tained from 
 
z
 
100 g of rat liver tissue.
We obtained three endoproteolytic fragments of the 75-kD
protein. One of these peptides (highlighted sequence in
Fig. 2) was long enough for us to design a “guessmer” of
45 nucleotides that was then used to screen a rat thyroid
lambda Uni-ZAP cDNA library. A single clone of 2,056-bp
was isolated containing a single continuous open reading
frame of 1,833-bp with a TAG termination codon followed
by a 3
 
9
 
-untranslated region containing a polyadenylation
signal as well as a poly-A tail. This open reading frame
contained all three peptide sequences obtained directly
from the 75-kD protein (underlined sequences in Fig. 2).
Figure 1. (A) Nucleoporins
immunoadsorbed from rat
liver nuclear envelopes using
QE5-Sepharose beads (lane
2). The material shown is de-
rived from 1 to 2 g of rat liver
and is revealed by silver
staining. Approximately 50–
1003 this quantity was used
for limited amino acid se-
quence analysis of Nup84.
Molecular weight markers
(indicated in kD) are shown
in lane 1. ( B ) Western blot
analysis of QE5 and anti-
Nup214 immunoprecipitates
of NRK cells using an anti-
peptide antibody against
Nup84. Immunoprecipitates were washed either in a low stringency buffer containing 0.5% Triton X-100 (TX, lanes 1 and 3) that pre-
serves the Nup214–Nup84 interaction, or in a high stringency buffer containing 0.5% Triton X-100 plus 0.1% SDS (TX/SDS, lanes 2 and
4). This latter buffer breaks the interaction between Nup214 and Nup84 (Panté et al., 1994). (C) Indirect immunofluorescence labeling
of NRK cells using the anti-peptide antibody against Nup84. The nuclear envelope is clearly labeled.
Figure 2. Complete amino acid sequence of Nup84 derived from
cDNA sequence analysis. The boxed segments correspond to the
COOH-terminal predicted coiled–coil regions, which are most
closely related to members of the tropomyosin family. The pri-
mary structure of the underlined peptides was initially elucidated
by limited amino acid sequence analysis of Nup84 tryptic frag-
ments. The highlighted peptide (P1), also obtained by amino acid
sequence analysis, was used in the design of the oligonucleotide
employed in the isolation of the cDNA. The GenBank accession
number of the complete cDNA sequence is U93692. 
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This clone did not, however, contain the complete cDNA.
A Northern blot analysis performed using this clone as a
probe hybridized with a single transcript of 
 
z
 
2.6 kb. Al-
though variable in its expression levels, it is found in all tis-
sues as one would expect for a nucleoporin (data not
shown). The size of the transcript and the lack of an ATG
initiation codon indicated that we were missing around
400–500 bp from the 5
 
9
 
-end. To obtain the full-length cDNA
we carried out a modified version of the RACE (rapid am-
plification of cDNA ends) technique (Edwards et al.,
1991). A clone of about 600-bp containing a single putative
ATG initiation codon (Kozak, 1987) in the correct reading
frame was finally obtained.
The full-length cDNA encodes a protein (Fig. 2) com-
posed of 742 amino acid residues with a calculated molec-
ular mass of 83,531. Since it is a nuclear pore complex pro-
tein (discussed in more detail below), it will be referred to
as Nup84 following the current nomenclature convention.
It has a calculated pI of 6.04, very similar to that estimated
by two-dimensional gel electrophoresis (isoelectric focus-
ing) of the QE5 immunoprecipitate. When translated in
vitro, the full-length cDNA produced a single product of
the expected size (data not shown).
 
Nup84 Is A Novel Nucleoporin That Contains
Neither XFXG Nor GLFG Repeats and Has a Predicted 
Coiled–Coil COOH Terminus
 
A BLAST search with the Nup84 sequence revealed that
it is a novel protein of bipartite primary structure. The
COOH-terminal third of the Nup84 polypeptide, while
unique, does exhibit significant sequence similarity to a
number of coiled–coil molecules, most notably to the mem-
bers of the tropomyosin family, for which an experimental
three-dimensional model is available (Phillips et al., 1986).
The identity between rat brain tropomyosin (Lees-Miller
et al., 1990) and residues 500–742 of Nup84 is about 25%,
with similarity scores up to 50% (Fig. 2). These values are
strong indicators of a common structure and suggest that
the COOH-terminal domain of Nup84 forms a coiled–coil
structure (Sander and Schneider, 1991). Consistent with
the sequence comparison data, a general agreement was
found between the secondary structure predicted for the
Nup84 COOH-terminal region and the three-dimensional
structure of tropomyosin (Fig. 2). The NH
 
2
 
-terminal re-
gion of Nup84 displays no significant similarity to any
other known protein sequences. Secondary structure pre-
dictions for this part of the polypeptide suggest a globular
domain with a balanced presence of helices and B-strands.
Finally, Nup84 contains neither the XFXFG nor the GLFG
repeats that have been found in a number of other nucle-
oporins, including its partner, CAN/Nup214. While this
manuscript was under review, Fornerod et al. (1997) de-
scribed Nup88, a human CAN/Nup214-associated protein.
It is clear that Nup88 represents the human homologue of
rat Nup84 with which it shares 89% sequence identity.
 
Nup84 Is Associated with CAN/Nup214
 
To confirm that Nup84 does indeed correspond to the 75-kD
protein identified in nondenaturing QE5 immunoprecipi-
tates, we raised an antibody against a COOH-terminal
peptide predicted from the Nup84 cDNA sequence. When
Figure 3. Indirect immunofluorescence analysis of BHK cells ex-
pressing HA-Nup84 (A, C) or HA-Nup214 (B, D) at either low
(A, B) or high (C, D) levels. The monoclonal antibody used is
12CA5, which recognizes the HA epitope. At low expression lev-
els both proteins localize to the nuclear envelope, whereas at
higher levels they spill over into the cytoplasm. At these higher
levels their localizations appear quite distinct. While the cytoplas-
mic distribution of HA-Nup84 is largely uniform, HA-Nup214
tends to concentrate in unusual cytoplasmic foci. The immuno-
blot is of low stringency QE5 immunoprecipitates of BHK cells
expressing either HA-Nup84 (lane 1) or HA-Nup153 (lane 2).
The blot is probed with the anti-HA antibody (12CA5). Since
HA-Nup84 is not recognized by QE5, its appearance in the im-
munoprecipitate must be by virtue of its association with CAN/
Nup214. HA-Nup153 (lane 2) provided a positive control for the
QE5 immunoprecipitation (the monoclonal antibody QE5 recog-
nizes Nup153 and p62 in addition to CAN/Nup214). Bars: (A, B)
5 mm and (C, D) 10 mm. 
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immunoblots of QE5 immunoprecipitates from NRK cell
extracts were probed with the antipeptide serum, a single
band of the appropriate size was recognized (Fig. 1 
 
B
 
, lane
 
1
 
). In contrast, no signal was observed if immunoprecipi-
tates were subjected to stringent wash conditions that
break the interaction between CAN/Nup214 and its asso-
ciated protein (Fig. 1 
 
B
 
, lane 
 
2
 
). Similar analyses of immu-
noprecipitates carried out with an anti-CAN/Nup214 poly-
clonal antibody rather than with QE5 gave identical results
(Fig. 1 
 
B
 
, lanes 
 
3
 
 and 
 
4
 
). While this Nup84 antibody was
not ideal for immunocytochemistry, immunofluorescence
analysis of lightly fixed NRK cells revealed labeling of the
nuclear envelope, consistent with an association of Nup84
with CAN/Nup214 (Fig. 1 
 
C
 
).
To better examine the intracellular distribution of Nup84,
an influenza virus hemagglutinin epitope tag was placed at
its NH2 terminus and the protein expressed in BHK cells.
Immunofluorescence microscopy using an anti-HA anti-
body revealed a labeling pattern consistent with associa-
tion of HA-Nup84 with NPCs. At low levels of expression
there is clear punctate staining of the nuclear envelope
(Fig. 3 A), indistinguishable from what is seen with ex-
pressed HA-CAN/Nup214 (Fig. 3 B) as well as with HA-
Nup153 as we have recently reported (Bastos et al., 1996).
An identical labeling pattern is also observed with the an-
tinucleoporin monoclonal antibody QE5 (Bastos et al.,
1996; Panté et al., 1994). At higher expression levels, the
progressive accumulation of both proteins in the cyto-
plasm becomes apparent (Fig. 3, C and D). As will be ex-
panded upon below, under these conditions Nup84 and
CAN/Nup214 exhibit quite divergent behavior.
A further experiment was performed to determine if the
expressed HA-Nup84 associated with endogenous CAN/
Nup214. For this purpose detergent (Triton X-100) ex-
tracts were prepared from BHK cells expressing HA-
Nup84. These extracts were then immunoprecipitated with
QE5 and analyzed by Western blot employing the 12CA5
anti-HA monoclonal antibody. As shown in Fig. 3 (lane 1),
HA-Nup84 was clearly detectable in the immunoprecipi-
tate. Since Nup84 does not contain an epitope recognized
by QE5, its presence in the immunoprecipitate has to be
due to the interaction with CAN/Nup214. The results de-
scribed here (Figs. 1 and 3), taken together with previously
published biochemical data (Panté et al., 1994), confirm
that Nup84 and CAN/Nup214 are physically associated.
Since CAN/Nup214 is a component of the cytoplasmic
filaments of the NPC we would expect to find that its asso-
ciated protein, Nup84, also faces the cytoplasm. To deter-
mine whether this is the case, we performed immunofluo-
rescence microscopy on BHK cells, expressing HA-Nup84,
which were permeabilized with 0.004% digitonin on ice.
Under these conditions, the plasma membrane is perme-
abilized but the NE remains intact (Adam et al., 1990).
Therefore only those proteins on the cytoplasmic face of
the NPC can be accessible to the antibodies. As illustrated
in Fig. 4, the digitonin permeabilized cells show clear nu-
clear envelope labeling when the anti-HA antibody was
used (Fig. 4 C), but no labeling at all when an anti–lamin
A antibody was used (Fig. 4 D). This finding strongly sug-
gests that Nup84 is indeed exposed on the cytoplasmic
face of the NPC.
Nup84 and CAN/Nup214 Associate prior to Their 
Stable Integration into NPCs
Previous studies by Gerace and co-workers revealed that
many NPC glycoproteins (including CAN/Nup214) are re-
sistant to solubilization by low salt buffers containing Tri-
ton X-100 (Snow et al., 1987). Furthermore, purified nu-
clear envelopes extracted in this way, while lacking both
inner and outer nuclear membranes, exhibit morphologi-
cally identifiable NPCs anchored to a residual nuclear
Figure 4. Differential perme-
abilization of BHK cells tran-
siently expressing HA-Nup84.
Cells are double labeled
with the monoclonal anti-HA
(12CA5, A and C) and a rab-
bit anti-peptide antibody
against lamin A (B and D).
While 0.2% Triton X-100 (A,
B) permeabilizes both the
plasma membrane and the
nuclear membranes and al-
lows labeling by both anti-
bodies, 0.004% digitonin se-
lectively permeabilizes only
the plasma membrane. In
this case, HA-Nup84 is de-
tected at the nuclear periph-
ery but lamin A, which is lo-
calized on the nucleoplasmic
face of the nuclear envelope,
remains unlabeled. These re-
sults indicate that HA-Nup84
is exposed on the cytoplasmic
face of the nuclear envelope.
Bar, 10 mm.Bastos et al. The Function of Nup84 995
lamina (Gerace et al., 1984). We have taken advantage of
these observations to determine whether the stable assem-
bly of CAN/Nup214 into NPCs occurs before or after its
association with Nup84. To first define the solubility prop-
erties of total cellular CAN/Nup214, BHK cells that had
been labeled for 18 h (essentially to equilibrium) with 35S-
Trans label were lysed in a Triton-containing low salt (0
mM NaCl) buffer. After centrifugation, the pellet fraction
was reextracted at high salt (500 mM NaCl). Both high and
low salt extracts were then analyzed by immunoprecipita-
tion using the QE5 monoclonal antibody under conditions
that preserve the interaction of CAN/Nup214 with Nup84.
As shown in Fig. 5 (lanes 7 and 8) and consistent with the
published studies (Snow et al., 1987), 80–90% of the CAN/
Nup214 is resistant to solubilization at low salt. The oppo-
site result, however, was obtained when only newly syn-
thesized CAN/Nup214 was observed. After a 30-min pulse
label, greater than 90% of the newly synthesized CAN/
Nup214 was found to be soluble at low salt (Fig. 5, lanes 1
and 2). During a subsequent chase (up to 18 h) in medium
containing excess unlabeled methionine and cysteine,
CAN/Nup214 acquired resistance to solubilization with a
half-time of z1 h (Fig. 5, lanes 3–6). Since all available
data indicate that CAN/Nup214 is localized exclusively to
NPCs and at the same time cannot be extracted at low salt,
this solubility shift is most likely to reflect the stable inte-
gration of newly synthesized CAN/Nup214 into pore com-
plexes. A telling feature of this experiment is that newly
synthesized Nup84 associates with CAN/Nup214 very rap-
idly; in fact it becomes just detectable within the time
frame of the 30-min pulse. Furthermore, the complex formed
by these two molecules can be found in the low salt extract
(Fig. 5, lanes 1 and 3), which would imply that CAN/
Nup214 and Nup84 associate before their stable assembly
into NPCs. Nup153, like CAN/Nup214, exhibits a similar
decrease in solubility soon after synthesis, but with a some-
what shorter half-time. In contrast, a longer half-time (.1 h)
is observed for p62.
Nup84 May Function in the Attachment of CAN/
Nup214 to the NPC
Clues to the possible function of Nup84 were provided by
a series of transfection experiments, some in combination
with CAN/Nup214. When HA-tagged CAN/Nup214 is in-
troduced alone into BHK cells it associates with the nu-
clear envelope (Fig. 3). Like Nup84, as its expression level
rises and all available nuclear envelope binding sites are
saturated, CAN/Nup214 spills over into the cytoplasm
(Fornerod et al., 1995). At this point, however, all similar-
ity in the behavior of the two proteins vanishes. In contrast
to Nup84, which appears to distribute evenly throughout
the cytoplasm (Fig. 3 C), CAN/Nup214 localizes in part to
brightly labeled micron-scale foci visible against a general
cytoplasmic background (Fig. 3 D). To date, we have un-
fortunately been unable to identify an ultrastructural cor-
relate for these structures. However, they do not appear to
contain other nuclear envelope constituents such as lamins
(Fig. 6, A and B) or the NPC proteins Nup153 (not shown)
and gp210 (Fig. 6, C and D). Furthermore, these structures
are not labeled by antibodies against either the endoplas-
mic reticulum or a lysosomal marker, the transmembrane
gycoprotein LGP120 (not shown). Proteins that were,
however, associated with these foci were the two subunits
of the NLS receptor, importins or karyopherins-a and b
(Fig. 6, E–H). Consistent with this finding, we also noticed
the transient association of a nuclear import substrate with
these structures (Fig. 7). This observation was made in
BHKgrb cells (Bastos et al., 1996), which constitutively
express a glucocorticoid receptor–b-galactosidase fusion
protein (grb). This fusion protein localizes exclusively to
the cytoplasm until the addition of dexamethasone to the
culture medium, whereupon it translocates rapidly and
quantitatively into the nucleus (Picard and Yamamoto,
1987). When this translocation process was examined in
cells expressing high levels of HA-CAN/Nup214, the uni-
formly cytoplasmic grb was found to redistribute to the
foci as well as to the nucleus within a few minutes of dexa-
methasone treatment. Over a period of 1–2 h, grb associ-
ated with the foci was lost.
When BHK cells were cotransfected with Myc-Nup84
Figure 5. Pulse–chase analysis of NPC proteins in BHK cells la-
beled with 35S-Trans label. The cells were either labeled continu-
ously for 18 h (lanes 7 and 8) or pulse labeled for 30 min (lanes 1–6)
followed by a “chase” of 1 h (lanes 3 and 4) or 18 h (lanes 5 and 6)
in medium containing excess unlabeled methionine/cysteine. At
the appropriate time, the cells were lysed in a low salt buffer con-
taining Triton X-100. The distributions of CAN/Nup214 and
Nup84 between soluble and insoluble fractions were then deter-
mined by immunoprecipitation analysis using the QE5 mono-
clonal antibody (which recognizes CAN/Nup214, Nup153, and
p62). Total or bulk CAN/Nup214 (and associated Nup84) ob-
served in the samples derived from the continuously labeled cells
(lanes 7 and 8) is almost completely (80–90%) resistant to solubi-
lization. In contrast, following the 30-min labeling period, 90% of
newly synthesized CAN/Nup214 is found in the soluble fraction
(lanes 1 and 2) and, furthermore, coprecipitates with Nup84.
Both of these proteins are subsequently “chased” into the insolu-
ble fraction with a half-time of about 1 h (lanes 3 and 4). These
findings are consistent with the notion that the two proteins asso-
ciate before stable integration into the NPC. While derived from
the same experiment and run on the same gel, exposure times for
lanes 1–6 versus lanes 7 and 8 have been adjusted (11 d and 8 h, re-
spectively) to yield comparable intensities. The two bands indi-
cated by the diamonds, the upper of which migrates just ahead of
the p62-associated protein, p58, are both observed with nonim-
mune Sepharose beads.The Journal of Cell Biology, Volume 137, 1997 996
and HA-CAN/Nup214, each protein was found to strongly
influence the other’s distribution (Fig. 8, A and B). In the
case of Myc-Nup84 it localized both to the nuclear enve-
lope and to the CAN/Nup214 foci with little left free in the
cytoplasm. Similarly, cytosolic HA-CAN/Nup214 was found
to concentrate largely within the foci. These data indicate
that high concentrations of HA-CAN/Nup214 divert cyto-
plasmic Myc-Nup84 into the foci, while excess Myc-Nup84
promotes a further accumulation of HA-CAN/Nup214
within these structures. This colocalization and codepen-
dent redistribution clearly implies that these two proteins
interact in vivo.
To investigate these interactions further we made a
Myc-Nup84 mutant missing 140 residues from the COOH
terminus (Myc-Nup84D607). This mutant therefore lacked
about two thirds of the presumed coiled–coil tail. When
expressed in BHK cells, Myc-Nup84D607 localized only to
the cytoplasm with no detectable association with the nu-
clear envelope at any expression level (Fig. 9 A). How-
ever, cells expressing high levels of this mutant also exhib-
ited an accumulation of some endogenous (possibly only
newly synthesized) CAN/Nup214 in the cytoplasm (Fig. 9,
B–G). In contrast, overexpression of full-length Myc-
Nup84 had no such effect (Fig. 9, H and I). In cells trans-
fected with both Myc-Nup84D607 and HA-CAN/Nup214,
a codependent redistribution of both proteins was again
observed (Fig. 8, C and D). Both Myc-Nup84D607 and
HA-CAN/Nup214 localized exclusively to the foci with
neither exhibiting any clear nuclear envelope association
(Fig. 8, C and D). These results would suggest that while
Myc-Nup84D607 has lost the ability to associate with the
nuclear envelope it retains the capacity to interact with
CAN/Nup214. As will be expanded upon below, these
findings are consistent with a model in which Nup84 coop-
erates in the assembly of CAN/Nup214 into the NPC.
Discussion
Nup84 represents a new NPC protein identified on the ba-
sis of its interaction with CAN/Nup214. Although devoid
of characteristic peptide repeats such as XFXFG or GLFG,
Nup84 can be added to the growing list of nucleoporins
from a variety of sources that contain putative coiled–coil
domains. Indeed, it has recently been proposed (Hurwitz
Figure 6. Double indirect
immunofluorescence micros-
copy of BHK cells (A, B, E–H)
and HeLa cells (C and D)
transiently expressing HA-
CAN/Nup214. Cells were la-
beled with a monoclonal an-
tibody against the HA
epitope (12CA5, A, C, F, and
H) as well as rabbit antibod-
ies against lamin A (B), im-
portin-a (F), and importin-b
(H) and a human autoanti-
body recognizing the NPC
membrane protein gp210
(C). The same nuclei in A
and B are indicated with
stars. CAN/Nup214 cytoplas-
mic foci containing import-
ins-a and -b are indicated
with arrows in E–H. While
the importins clearly associ-
ates with the CAN/Nup214
cytoplasmic foci, these struc-
tures are negative for lamin
A and gp210. Bars (A–D and
E–H) 10 mm.Bastos et al. The Function of Nup84 997
and Blobel, 1995) that this feature may represent a major
structural motif through which nucleoporins interact. Ex-
amples of such a role for coiled–coils are provided by sev-
eral nucleoporins from both yeast and higher cells. The
vertebrate nucleoporin p62, which forms a complex with
three additional NPC proteins, p58, p54, and p45 (Finlay
et al., 1991; Guan et al., 1995; Kita et al., 1993; Panté et al.,
1994), has an a-helical coiled–coil COOH-terminal do-
main of about the same size as that of Nup84 (Buss et al.,
1994). This region of p62 has been shown to contain the
site of interaction with p54 (Buss and Stewart, 1995) that
itself has a predicted a-helical coiled–coil domain (Hu et
al., 1996). Predicted coiled–coils have been found in the
peptide repeat-containing yeast nucleoporins Nsp1,
Nup49, Nup57, Nup159, as well as in two other NPC pro-
teins NIC96 (Grandi et al., 1993) and Nup82 (Grandi et
al., 1995a). Hurt and co-workers have shown, both bio-
chemically and genetically, that Nsp1, Nup49, Nup57, and
NIC96 are all associated and that, as in the case of p62/
p54, this association may be mediated by their helical do-
mains (Grandi et al., 1995b).
The finding that Nup84 and CAN/Nup214 are associ-
ated raises the issue of where this association initially
takes place, either in the cytosol soon after synthesis or
within the pore complex itself. Pulse–chase experiments
involving differential salt extraction procedures indicate
that newly synthesized CAN/Nup214 and Nup84 associate
fairly swiftly (within 30 min of synthesis), at a time when
they are still soluble at low salt. Since NPC-associated
CAN/Nup214 is resistant to solubilization under these
conditions, this suggests that association of CAN/Nup214
with Nup84 occurs in the cytoplasm, or at least before
their stable assembly into NPCs. This view is supported by
the results of the cotransfection studies involving Myc-
Nup84 and HA-CAN/Nup214, which clearly indicate that
these proteins must be capable of interacting while still cy-
toplasmic. By analogy with other complex self-assembly
systems such as bacteriophage T4, the association of Nup84
and CAN/Nup214 to form a soluble heterooligomer might
actually be a prerequisite for the incorporation of either
molecule into the NPC. The same could also be true for
the p62/58/54/45 subcomplex since our preliminary obser-
Figure 7. Double indirect immunofluorescence microscopy of BHKgrb cells transiently expressing HA-CAN/Nup214. 24 h posttrans-
fection and before fixation, the cells were treated with dexamethasone for periods up to 3 h as indicated at the top of the figure. The pri-
mary antibodies were 12CA5 (anti-HA, upper row) and a rabbit anti–b-galactosidase (corresponding fields, lower row). It is evident that
there is a transient association of glucocorticoid receptor–b-galactosidase with the CAN/Nup214 foci shortly after the addition of dexa-
methasone (indicated with arrows in C and D). This is consistent with the observation that importins-a and -b are also associated with
these structures (Fig. 6). Bar, 10 mm.The Journal of Cell Biology, Volume 137, 1997 998
vations suggest that these proteins at least associate rela-
tively rapidly (Fig. 5 and unpublished results). In contrast,
the rate at which p62 becomes nuclear envelope associated
(half-time of 6–8 h in nonsynchronized BRL cells) is ex-
ceedingly slow (Davis and Blobel, 1986, 1987). In this way,
de novo formation of NPCs during interphase may involve
the prefabrication of NPC modules which are subse-
quently assembled to yield mature NPCs. Certainly this
type of modular NPC assembly, at least with respect to
p62, appears to be the rule during nuclear reformation at
the end of mitosis (Finlay et al., 1991).
The association with CAN/Nup214, a component of the
NPC cytoplasmic filaments, suggests that Nup84 should be
exposed on the cytoplasmic face of the nuclear envelope, a
prediction borne out by differential permeabilization stud-
ies of transfected BHK cells. Appropriate targeting of
Nup84 is contingent upon the integrity of it its COOH-ter-
minal coiled–coil domain since a mutant in which two
thirds of this region is deleted (Nup84D607) is found to re-
Figure 9. Expression of HA-Nup84D607 in BHK cells. HA-Nup84D607, detected with 12CA5, localizes exclusively to the cytoplasm re-
gardless of expression level (A). No association with the nuclear envelope is evident. In B–G, the effects of HA-Nup84D607 expression
(B, D, and F) on endogenous CAN/Nup214 localization (C, E, and G), detected with guinea pig anti–CAN/Nup214 are shown. It is ap-
parent that HA-Nup84D607 overexpression causes mislocalization of some of the endogenous CAN/Nup214 to the cytoplasm. For com-
parison, the effects of full-length HA-Nup84 (H) are also shown. In this case there is no obvious effect on endogenous CAN/Nup214 lo-
calization (I). Bars (A and B–I) 10 mm.
Figure 8. Double indirect immunofluorescence microscopy of
BHK cells cotransfected with expression constructs containing ei-
ther HA-Nup214 and Myc-Nup84 (A and B) or HA-Nup214 and
Myc-Nup84D607 (C and D). The antibodies used were a mono-
clonal anti-Myc (9E10, A and C) and a rabbit anti–HA (B and
D). It is clear from this figure and from the results presented in
Figs. 3 and 9 that there is a codependent distribution of HA-
Nup214 and both Myc-Nup84 and Myc-Nup84D607. Both Nup84
constructs concentrate in HA-Nup214 foci in the cytoplasm (indi-
cated by the arrows) while there is diminution in the amount of
HA-Nup214 localized to the nuclear envelope (compare with
Figs. 3 and 5). These results provide strong, albeit circumstantial,
evidence that both Myc-Nup84 and Myc-Nup84D607 possess the
capacity to associate with Nup214. Bar, 10 mm.Bastos et al. The Function of Nup84 999
main cytosolic. This is in marked contrast to the behavior
of full-length Nup84, and also to CAN/Nup214, which
both localize exclusively to the nuclear periphery when ex-
pressed at low levels. Interaction with CAN/Nup214 is ap-
parently not sufficient to correctly localize Nup84. This
view is based on our observations that Nup84D607, like
full-length Nup84, codistributes with CAN/Nup214 when
both proteins are expressed at high levels in BHK cells.
These results may at first seem paradoxical since one
might expect that interaction of Nup84D607 with CAN/
Nup214 should be able to confer NPC association on the
former. The fact that it does not suggests a scheme in
which Nup84 functions in the integration of CAN/Nup214
into the NPC. This could potentially involve Nup84 acting
as a linker between CAN/Nup214 and the central region
of the NPC. In such a model Nup84 would be expected to
interact with CAN/Nup214 via its globular NH2-terminal
domain, while its COOH-terminal a-helical domain would
mediate attachment to the central framework of the NPC.
A variation on this theme would be to suggest that the as-
sociation of Nup84 with CAN/Nup214 results in the for-
mation of a new binding domain that is required for the in-
teraction of the CAN/Nup214-Nup84 module with the
NPC central framework. Such a role for Nup84 in CAN/
Nup214 NPC-association is lent some credence by the
finding that overexpression of Nup84D607 results in a par-
tial accumulation of endogenous (most likely newly syn-
thesized) CAN/Nup214 to the cytoplasm. The relative dis-
positions of these two proteins, as well as their interactions
within the NPC, will be more precisely defined as anti-
Nup84 antibodies suitable for high resolution EM-immu-
nolocalization become available.
Overexpression of Nup84 (as well as Nup84D607)
yielded no detectable transport related phenotype, at least
in terms of nuclear protein import and poly (A)1 RNA ex-
port (Enarson, M., R. Bastos, and B. Burke, data not
shown). However, its partner protein, CAN/Nup214, when
expressed at high levels was found to cause the transient
diversion of an inducible nuclear import substrate (grb)
into unusual cytoplasmic foci. These foci were also found
to contain both importins-a and -b but were devoid of
other NPC and nuclear envelope proteins (as well as ER
and lysosomal proteins). At the same time no obvious ef-
fect could be observed on RNA trafficking (Bastos et al.,
1996). These findings would be consistent with CAN/
Nup214 or another associated nucleoporin containing
docking sites for incoming nuclear proteins complexed
with the NLS receptor. Support for such a role is provided
by the earlier observations of Richardson et al. (1988) and
more recently of Panté and Aebi (1996) that a nuclear im-
port substrate, nucleoplasmin-coated colloidal gold parti-
cles, associates with the cytoplasmic filaments of the NPC
at an early step in translocation. Furthermore, biochemical
data indicate that the NLS receptor complex associates in
vitro with the peptide repeat domains of certain nucle-
oporins (Morioianu et al., 1995; Radu et al., 1995), CAN/
Nup214 being one of these, an interaction that is regulated
by essential soluble import factors, including the small
GTP-binding protein Ran (Melchior et al., 1995; Nehrbass
and Blobel, 1996; Paschal and Gerace, 1995; Rexach and
Blobel, 1995). A role for CAN/Nup214 in nuclear protein
import is also indicated by the recent knockout data of
Grosveld and colleagues (van Deursen et al., 1996). In ad-
dition, nuclear accumulation of poly (A)1 RNA in CAN/
Nup214(2/2) embryos suggested a potential function in
RNA export. However, as pointed out by van Deursen et
al. (1996), this could be secondary to the import defect.
In summary, we have identified a new nucleoporin,
Nup84, which is proposed to function in the assembly of
CAN/Nup214 on the cytoplasmic face of the NPC. Since
CAN/Nup214 or an additional associated protein may
contain docking sites for incoming nuclear proteins, the
role of Nup84 may be to organize these sites at the cyto-
plasmic periphery of the NPC. This proposed role in CAN/
Nup214 attachment clearly implies that Nup84 may inter-
act with additional NPC components at the base of the cy-
toplasmic filaments, most likely in the cytoplasmic ring of
the central framework. Since this is a largely uncharted re-
gion, the identification of new Nup84-associated proteins
should provide important new information concerning the
organization of the cytoplasmic face of the NPC.
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